English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodies

MPS-Authors
/persons/resource/persons137849

Reiländer,  Helmut
Department of Molecular Membrane Biology, Max Planck Institute of Biophysics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Jahns, R., Siegmund, C., Jahns, V., Reiländer, H., Maidhof, A., Müller-Esterl, W., et al. (1996). Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodies. European Journal of Pharmacology, 316(1), 111-121. doi:10.1016/S0014-2999(96)00654-1.


Cite as: http://hdl.handle.net/21.11116/0000-0007-133A-3
Abstract
In order to generate antibodies suitable for immunological studies on β-adrenoceptors constitutively expressed at low levels in cells or tissues we have produced fusion proteins of the amino- and carboxy-terminus, and the second extracellular loop of the human β1- or β2-adrenoceptors with bacterial glutathione-S-transferase in E. coli. Rabbit antibodies raised against these fusion proteins strongly reacted with intact human β1- or β2-adrenoceptors in a subtype- and domain-specific manner. Antibodies directed against the second extracellular loop of the β1-adrenoceptor reacted stronger with non-denatured receptors and decreased the affinity of the 3H-labelled antagonist (−)-4-(3-t-butylamino-2-hydroxypropoxy)-[5,7-3H]benzimidazol-2-one ([3H]CGP 12 177), indicating a specific interaction with the native receptor. In contrast, antibodies directed against carboxy- and amino-terminal receptor domains reacted strongly both with denatured and non-denatured receptors but did not interfere with binding of [3H]CGP 12 177. Affinity purified antibodies were used for detecting the β1- or the β2-adrenoceptor subtype heterologously produced in Sf9 cells by enzyme-linked immunosorbent assay, Western blotting, immunoprecipitation, and indirect immunofluorescence microscopy. Moreover, we could demonstrate that avidity, titers, and specificity of these antibodies were high enough for studying β-adrenoceptors constitutively expressed in human A431 cells, where we observed a patched membrane distribution of the receptors.